The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticlesFull Access

Psychodynamic Psychotherapy for Patients With Functional Somatic Disorders and the Road to Recovery

Abstract

Patients with functional somatic disorders (FSDs) are commonly encountered in clinical practice and are often considered difficult to treat. This article summarizes recent advances in the understanding of these disorders that have opened new avenues for treatment. Findings concerning the role of three related key biobehavioral systems (attachment, mentalizing, and impairments in epistemic trust) that seem to be centrally involved in FSDs, as viewed from a psychodynamic perspective, are discussed as well as empirical evidence supporting the efficacy of psychodynamic psychotherapy for patients with FSDs. Finally, the basic treatment principles of dynamic interpersonal therapy, an integrative psychodynamic treatment adapted for patients with FSDs, are outlined through a description of the treatment of a woman with chronic widespread pain and irritable bowel syndrome.

Highlights

  • Psychodynamic treatment has been shown to be effective in the treatment of functional somatic disorders (FSDs).

  • Recent advances in the understanding and treatment of FSDs from a psychodynamic perspective open important new avenues for the treatment of patients with these disorders.

  • Although individuals with FSDs have often been labeled “hard to reach” and difficult to treat, this group of patients is heterogeneous, and many patients are open to psychological treatment.

Patients with persistent somatic complaints are commonly encountered in clinical practice. A meta-analysis (1) encompassing 32 studies in 24 countries (total N=70,085 patients) found that approximately 30% of patients seen in primary care fulfill criteria for somatic symptom disorder, and up to 50% of patients present with at least one somatic complaint. Psychotherapists often describe these patients as “hard to reach” or difficult to treat. These labels are not entirely correct, however, because many of these patients are open to psychological treatment. Recent advances in our understanding of these patients and their treatment suggest that even the most severely affected patients who primarily attribute their symptoms to somatic causes can be helped with psychotherapy, including psychodynamic psychotherapy (PDT). Indeed, there is increasing evidence (25) of the effectiveness of PDT for this patient group. A recent meta-analysis (6) of 17 randomized controlled trials showed that brief PDT was superior to minimal treatment, treatment as usual, and the waitlist control condition, with small to large effect sizes, and that brief PDT performed at least as well as other bona fide psychological therapies. Treatment results were maintained in the long term. Moreover, there is growing evidence (7) for the effectiveness of multidisciplinary, multicomponent, psychodynamically oriented treatment programs for these patients. Consistent with these findings, PDT has been associated with changes in neural systems involved in FSDs, including the stress, reward, and mentalizing systems (8).

Editor’s Note: This article is part of the special issue “Consultation-Liaison Psychotherapy,” guest edited by Jonathan Hunter, M.D., F.R.C.P.C. Although authors were invited to submit manuscripts for the themed issue, all articles underwent peer review as per journal policies.

In this article, we provide a brief overview of psychodynamic approaches to FSDs and describe the treatment principles of dynamic interpersonal therapy (DIT), an integrative PDT. In addition, we illustrate these principles with a brief clinical vignette.

An Attachment and Mentalizing Approach to FSDs

The Nature of FSDs

FSDs are notably heterogeneous with respect to the role of psychological and biological factors in their development. It is therefore typically impossible to determine the relative role of biological and psychological factors in an individual case. We have found it crucial to acknowledge, with humility, our lack of understanding of the precise causation of a patient’s symptoms. In light of the increasing evidence of the role of biological factors in most, if not all, FSDs, such an attitude also aligns with our current knowledge of the pathogenesis of these disorders (3, 9, 10). Acknowledging humility with regard to the cause of functional somatic symptoms characteristically has a normalizing and a validating effect on patients, who have often had to “prove” they are ill, have been told that their symptoms are all in their head, and/or have had conflicts with health professionals about the origin of their complaints. It is therefore also imperative to ensure that the patient has undergone thorough medical screening.

Our approach focuses on three key areas that, in various combinations, may be identified as predisposing, precipitating, or perpetuating factors: attachment issues, capacity for embodied mentalizing (i.e., the capacity to reflect on one’s own [embodied] self and others), and capacity for epistemic trust (i.e., the capacity to trust others, including clinicians, as a source of knowledge). Problems related to each of these factors may be implicated in the development of the disorder, but they may also result from or be exacerbated by somatic complaints. There is abundant research demonstrating the pernicious impact of FSDs on attachment, mentalizing, and epistemic trust, particularly among patients whose symptoms have become chronic (10).

Attachment.

From a neurobiological perspective, FSDs may be best conceptualized as reflecting a state of allostatic load as a result of prolonged physical and/or psychological stress and conflict (11). Allostatic load refers to a temporary or chronic disruption of the dynamic equilibrium (allostasis) that characterizes the human stress response and associated neurobiological systems (the stress, immune, and pain-regulating systems) and biomediators.

Attachment issues play a crucial role as either a vulnerability factor or as a secondary factor. The attachment system is a biobehavioral system that is centrally involved in the stress response, as during development humans learn to seek proximity to attachment figures when confronted with distress. When attachment figures are available and responsive, the distress is typically down-regulated (Figure 1) because the individual feels supported, cared for, and loved (12, 13). A mesocorticolimbic dopaminergic reward system underlies this process, as it generates the feeling of reward associated with secure attachment experiences and down-regulates the stress system at both the biological (i.e., the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system) and behavioral levels (14).

FIGURE 1.

FIGURE 1. Relationship between the attachment and stress-regulation systemsa

aStress regulation system in secure attachment (A) and in insecure attachment (B).

Chronic persistent somatic problems preclude the effective down-regulation of distress; proximity seeking provides, at best, only partial relief. Hence, as the normative down-regulation of distress increasingly fails, the individual resorts to secondary attachment strategies (15). These strategies comprise either hyperactivation of the attachment system involving increasingly desperate efforts to find support and relief in others, deactivation of the attachment system leading to a denial of distress and/or need for help and support, or a combination of the two. Secondary attachment strategies are unconscious strategies that represent an attempt to adapt to the ever-increasing threat from within that is posed by the chronic fatigue and pain associated with FSDs. Although secondary attachment strategies may bring some short-term relief, in the long run they negatively affect the patient’s condition and particularly the patient’s ability to seek help (including psychological help) from others and to benefit from it (Figure 1). As allostatic load further increases, individuals who rely on attachment hyperactivating strategies desperately attempt to find support and relief but become increasingly disappointed in others, in particular health professionals (and especially health professionals who attempt to force a specific illness theory on them). For patients who primarily use attachment deactivating strategies, feelings of loneliness and bitterness emerge, and the wear and tear of allostatic load on the biological stress system and psychological capacities often lead to a complete breakdown, such that the patient feels overwhelmed, depressed, and anxious (16).

Among patients with premorbid attachment problems in particular, this process may lead to negative idealization–denigration cycles. In the context of therapy, this results in intensive transference–countertransference issues, where the therapist feels either idealized, denigrated, or even manipulated. These issues seem to be largely responsible for the view that patients with FSDs are difficult to treat (17, 18). Yet, from the patients’ perspective, their overreliance on secondary attachment strategies and the resulting behaviors are an understandable adaptation strategy.

Mentalizing.

The combination of persistent somatic symptoms and the use of secondary attachment strategies characteristically erodes patients’ mentalizing capacities—in particular, their capacity for embodied mentalizing. Embodied mentalizing involves the capacity to perceive and reflect on bodily signals (i.e., interoception) as representative of inner mental states and one’s selfhood. Feelings of pain and fatigue progressively impair and distort this capacity as the body is increasingly conceived of as a hostile entity that threatens the coherence of the self from within (19). For some patients, problems with embodied mentalizing may precede the onset of FSD symptoms; in others, such problems arise as a consequence of debilitating pain and fatigue and/or are exacerbated by these symptoms. Consistent with these assumptions, research has demonstrated problems with both primary or secondary alexithymia (20) and emotional awareness (21) among patients with FSDs. Impairments in embodied mentalizing characteristically give rise to the reactivation of nonmentalizing modes of experiencing the embodied self, with which clinicians working with these patients are familiar (Box 1).

BOX 1. Typical nonmentalizing modes among patients with functional somatic disorders
Psychic Equivalence Mode
  • Inner (mental) and outer reality are equated (“I think there is a virus causing my problems, so there must be a virus causing my problems”).

  • Therapeutic response: validating the patient’s perspective while recognizing uncertainty and humility with regard to the precise causes of somatic problems.

Teleological Mode
  • • Only observable causes (e.g., severe physical abuse) or biological factors (e.g., a virus, tumor, or poisoning) can cause psychological and/or somatic complaints.

  • • Therapeutic response: validation, then focus on the embodied experience of feelings related to somatic problems and how these feelings relate to current (interpersonal) problems through the process of “microslicing.”

Pretend Mode
  • The patient’s thoughts and feelings become decoupled from the external world and may give rise to excessive rumination and even dissociation of thought (hypermentalizing or pseudomentalizing).

  • Therapeutic response: “rewinding” to when the patient lost the capacity to mentalize and explore what interpersonal situation was reactivated that led to the loss of mentalizing (e.g., “I felt rejected again” or “I felt humiliated”).

Epistemic trust.

Over the past few years, we have become acutely aware of the role of problems with epistemic trust, the capacity to trust others as reliable sources of knowledge about the world (including knowledge about one’s symptoms) in FSDs. Many patients with FSDs, particularly those with a history of early adversity, have had problems with epistemic trust before the onset of their functional somatic problems. These patients’ distrust of others—including health professionals who argue that the patients’ complaints are wholly psychosomatic and without any biological basis—further erodes these patients’ epistemic trust. As a result, many patients feel misunderstood and invalidated (22). Hence, the first therapeutic task when working with these patients is to validate the reality of their suffering and their symptoms. If this is not done, psychotherapeutic interventions will often be iatrogenic because they will increase the patients’ feelings of invalidation and epistemic distrust (23).

Treatment Approach

Dynamic interpersonal therapy for FSD (DIT-FSD) is an integrative PDT that focuses on the three core features of patients with FSD discussed above: the activation or reactivation of secondary attachment strategies to deal with persistent somatic problems, the resulting impairments in embodied mentalizing, and problems with epistemic trust (9, 24).

Because patients with FSDs are notably heterogeneous with respect to the nature and origins of their problems, the ability to tailor treatment to patients’ needs and capacities is a central feature of DIT-FSD. For patients with more severe impairments in embodied mentalizing, therapy typically focuses on reactivating the capacity for embodied mentalizing before any work focusing on the content of the patient’s interpersonal dynamics can be done successfully. In DIT-FSD, this latter focus is based on the therapist and patient jointly formulating an interpersonal affective focus (IPAF)—a description of a recurring and often unconscious pattern of relating to the self and others that is linked to the onset and perpetuation of functional somatic problems.

DIT-FSD is offered in a 16-session format or, for patients with more severe symptoms, in a 26-session format. The time-limited nature of the treatment provides patients with a holding environment and activates the patient’s IPAF (e.g., “Why do I need such a long treatment? I have always been able to take care of things on my own,” or “Sixteen sessions will be way too short, I need many more”). Of course, at the end of DIT-FSD, some patients may benefit from longer treatment, but the aim of DIT-FSD is to empower the patient to continue his or her own treatment process as needed.

In what follows, we describe the 16-session format based on a brief summary of the treatment of Linda, a woman with severe and chronic gastrointestinal problems (all case material has been disguised to protect patient confidentiality).

The first phase of DIT-FSD (sessions 1–4) focuses on engaging the patient in treatment and jointly formulating an IPAF, however preliminary, as the focus of the treatment. Linda was referred to me (P.L.) after having suffered for years from severe and almost constant gastrointestinal problems. She had been diagnosed as having irritable bowel syndrome and chronic widespread pain, and she had undergone numerous medical tests and examinations in the past. Each time, she was told that her condition must largely be stress-related and that she needed to see a psychologist or psychiatrist.

During her intake interview, Linda told me that she had seen several psychologists, but none of them seemed to have understood her; they all seemed to agree with the view that her symptoms and complaints were largely psychological. Each time, after a few sessions, she terminated treatment. In DIT, this narrative is seen as a cautionary tale: the patient warns the therapist of not only what might reoccur in the therapeutic relationship (“people, including you as a therapist, do not understand me”) but also of what might happen if the therapist is yet another person who does not understand her (she will end the treatment). Because this template or pattern might also prove to be a central component of Linda’s IPAF, my initial response was to validate and normalize her adaptation strategy, expressing my surprise that both physicians and psychologists had not taken her seriously and saying that it must have been terrible given that she clearly was in pain and feeling desperate. In response, she started to cry. She then looked up and asked me whether I believed her. I told her that she did not need to convince me of the reality of her symptoms or of her feelings of desperation and depression because no one seemed to be able to help or even to understand her.

Hence, my empathic validation of her feelings of invalidation and recognition of the reality of her suffering led to a relaxation of her epistemic vigilance and the emergence of an interest in what else I thought about her and her problems. Together, we were then able to discuss whether she had experienced the feeling of not being understood before. This exchange led to an attachment memory: as a child, Linda always had the feeling that she was “second best” and that her parents, particularly her mother, preferred her sister. Throughout her childhood and adolescence, she had always attempted to be her “mother’s darling,” but she always seemed to fail to surpass her sister in this regard. She became desperate for her mother’s attention and felt very anxious whenever her mother seemed to disapprove of something that Linda did or wanted. When she was 10 or 11, Linda began to develop gastrointestinal symptoms. When I asked how she felt as a child and as a teenager, Linda responded that she felt constantly anxious and on guard. When I asked whether these feelings also may have taken a toll on her body (i.e., an embodied mentalizing focus), she responded that this was true: she always felt tense, as if there was a weight on her shoulders and a constant pressure in her stomach. I asked whether she now felt the same tension and pressure during the session. Linda responded that she had never thought of the connection between her anxious preoccupation with her mother and her gastrointestinal symptoms, but that in the here-and-now of the session, she felt that there must be a link between the two.

In DIT-FSD, we do not force a specific illness theory on the patient, but use interventions aimed at fostering embodied mentalizing so that the patient begins to experience possible links between a repetitive interpersonal pattern and somatic symptoms through “microslicing” of interpersonal events (i.e., exploring undifferentiated mental states in relation to interpersonal events in a step-by-step manner to break them down into specific mental states that are meaningfully linked to each other). This experience led Linda to talk about other relationships in which this anxious pattern of wanting to be the one who is preferred over others had recurred (with a teacher, with a man who gave her lessons at a pony club, and with two boyfriends she had dated before meeting her current partner). In her current relationship, she said that this pattern seemed to be somewhat less important because her partner was “extremely patient with her” (which could also be read as a cautionary tale).

In session 3, we were able to jointly arrive at a preliminary formulation of her IPAF. She saw herself as someone who was always there for others, caring for and helping them. However, she experienced others as being uncaring and as preferring other people, despite doing her utmost to please them. This experience made her feel sad, lonely, and despondent, but also highly anxious because it meant, in her experience, that no one really cared for her and that she was “all alone in the world” (an example of psychic equivalence functioning). Importantly, we were able to consider this pattern as an understandable adaptation strategy given the context in which she grew up. However, this strategy also had a large emotional and somatic cost: not only did she feel anxious and alone, she always felt tense and on guard, and she always felt as if there was “something on her stomach,” giving her cramps.

When we focused on her cramps and the feeling that there seemingly was always “something on her stomach,” she could, at first very cautiously and with a lot of shame, acknowledge that she also often felt frustrated and angry because others neglected her and did not understand her. She recalled, for instance, how one day when her sister had organized a barbecue for the whole family, Linda had felt so tense, frustrated, and angry that she had to leave early because she felt nauseated and had to vomit. She had left the barbecue without telling anyone and without mentioning that she felt unwell. Hence, her feelings of anger and frustration typically gave rise to high levels of bodily arousal and tension, which contributed to her gastrointestinal problems. Feelings of guilt inhibited her anger until the whole cycle started again. Linda, however, had always attributed her cramps to a somatic cause (an example of teleological functioning).

The second phase of DIT (sessions 5–12) involves a constant focus on how the IPAF recurs in the patient’s life. In addition, once the therapy has strengthened the patient’s capacity to reflect on the negative impact of this repetitive pattern of thinking and feeling and its link with presenting symptoms, the therapist and patient can jointly begin to consider alternative ways of relating to the self and others. This process is typically accompanied by an alleviation of the patient’s symptoms.

Although Linda initially remained somewhat reluctant to talk about her family and current relationships, she increasingly began to acknowledge—first during the sessions and then, as the treatment progressed, in the wider world—how her feelings of not being seen or understood weighed on her both symbolically and literally. In other words, she acknowledged how she had always felt oppressed and suppressed and how these feelings had led to a constant state of anxious tension. The emotional and physical costs of her expectation that others would not be there for her and that they preferred others above her became increasingly clear. At this point in the therapy, both her general feeling of being tense and her more specific gastrointestinal problems began to improve markedly. Not only did she feel less of a need to be “preferred” by others, she reported feeling more relaxed in the company of others. In addition, her almost endless worrying that others did not like her because of something she said or did not say, or did or did not do (which led to anxious thoughts about rejection and abandonment that often preoccupied her for days, an example of pretend mode functioning) considerably decreased. The fact that her partner continued to be supportive and reassuring played an important role in this context. She also began to distance herself more from her mother and sister and from friends whom she felt exploited her tendency to care for others and always be there for them. In the middle phase of treatment, DIT uses the full spectrum of interventions typically used in PDT. This spectrum includes supportive interventions when needed, interventions that foster embodied mentalizing, insight-oriented interventions (i.e., clarification, challenge, and interpretation), and directive interventions to encourage the patient to bring about changes related to their IPAF.

In the ending phase (sessions 13–16), the focus is on empowering the patient so that he or she can continue the process of change after the treatment ends. The ending phase typically starts by the therapist sharing a draft “goodbye” letter that contains an overview of the patient’s presenting problems, the jointly agreed upon IPAF formulation, the changes that have been achieved in treatment, and a summary of what remains to be achieved. The patient is then invited to read the letter out loud and to suggest any changes that he or she feels are needed. The letter provides another important opportunity to work through the IPAF because it typically reactivates the patient’s IPAF. Linda, for instance, became silent when handed the letter. She read the letter, seemingly without any emotion, and said she did not have any comments on it. When I asked whether the letter conveyed the work that we had done together, she nodded. However, because she knew the letter introduced the last phase of treatment, she added that it left her feeling that I had probably had enough of her and wanted to get rid of her because there must be other, more interesting, patients who wanted to see me. When I suggested that perhaps this was Linda’s old pattern being reactivated, she nodded and said she was surprised it could still be that powerful. This statement led to in-depth exploration of how she would deal with similar experiences when her old pattern might be reactivated in the future. Much of the final few sessions was used to examine the extent to which the old pattern remained active in her daily life and the extent to which she had already internalized other ways of looking at herself and others. By the end of the treatment, she was able to express gratitude toward me and the treatment; although she still had occasional gastrointestinal problems, her symptoms had become markedly better. In the final session, she wanted to discuss whether her symptoms had biological roots and therefore might never resolve completely. She said she remembered that during our first session, I had said that I believed her symptoms were real and not imagined and that this had given her the feeling that I was truly listening to her and thus that I could help her (an example of the restoration of epistemic trust).

Conclusions

For many years, patients with FSDs were often considered hard to reach and difficult to treat. However, these labels neglect the fact that this group of patients is heterogeneous and that many of these patients are open to psychological treatment. Moreover, the perception of a subset of these patients as being hard to reach primarily resides in the eye of the beholder (i.e., medical professionals and therapists). Many of these patients have grown up in an invalidating, traumatizing environment in which epistemic distrust and hypervigilance were, at least in the short term, adaptive. Combined with often severe attachment disruptions and impairments in embodied mentalizing, this adaptation strategy increasingly gives rise to considerable psychological and metabolic costs, particularly when combined with biological vulnerability. Moreover, invalidating responses by others, including mental health professionals who often (even with good intentions) attempt to force specific illness theories (e.g., “Stress must play an important role in your symptoms”) on these patients, further increase the patients’ epistemic vigilance.

However, once epistemic vigilance is lifted by an approach that begins by validating and normalizing the patient’s adaptation strategy, as is typical of DIT-FSD and many other contemporary treatments, the road to recovery opens, and even patients with the most severe impairments can make considerable therapeutic progress. However, it may take considerable time for these patients’ FSD symptoms to fully resolve, particularly for patients with more chronic conditions, because of what seem to be deeply ingrained impairments in biological systems involved in the stress response that result from years of wear and tear, as well as deeply ingrained negative patterns of relating to the self and others.

Faculty of Psychology and Educational Sciences, University of Leuven, Leuven, Belgium (Luyten); Research Department of Clinical, Educational and Health Psychology, University College London, London (both authors).
Send correspondence to Dr. Luyten ().

The authors report no financial relationships with commercial interests.

References

1 Haller H, Cramer H, Lauche R, et al.: Somatoform disorders and medically unexplained symptoms in primary care. Dtsch Arztebl Int 2015; 112:279–287MedlineGoogle Scholar

2 Abbass A, Kisely S, Kroenke K: Short-term psychodynamic psychotherapy for somatic disorders. systematic review and meta-analysis of clinical trials. Psychother Psychosom 2009; 78:265–274Crossref, MedlineGoogle Scholar

3 Luyten P, Van Houdenhove B, Lemma A, et al.: An attachment and mentalization-based approach to functional somatic disorders. Psychoanal Psychother 2012; 26:121–140CrossrefGoogle Scholar

4 Sattel H, Lahmann C, Gündel H, et al.: Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry 2012; 200:60–67Crossref, MedlineGoogle Scholar

5 Guthrie E, Moghavemi A: Psychodynamic-interpersonal therapy: an overview of the treatment approach and evidence base. Psychodyn Psychiatry 2013; 41:619–635Crossref, MedlineGoogle Scholar

6 Abbass A, Town J, Holmes H, et al.: Short-term psychodynamic psychotherapy for functional somatic disorders: a meta-analysis of randomized controlled trials. Psychother Psychosom 2020; 1–8CrossrefGoogle Scholar

7 Koelen JA, Houtveen JH, Abbass A, et al.: Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. Br J Psychiatry 2014; 204:12–19Crossref, MedlineGoogle Scholar

8 Abbass AA, Nowoweiski SJ, Bernier D, et al.: Review of psychodynamic psychotherapy neuroimaging studies. Psychother Psychosom 2014; 83:142–147Crossref, MedlineGoogle Scholar

9 Luyten P, Van Houdenhove B, Lemma A, et al.: Vulnerability for functional somatic disorders: a contemporary psychodynamic approach. J Psychother Integration 2013; 23:250–262CrossrefGoogle Scholar

10 Luyten P, De Meulemeester C, Fonagy P: Psychodynamic therapy in patients with somatic symptom disorder; in Contemporary Psychodynamic Psychotherapy: Evolving Clinical Practice. Edited by Kealy D, Ogrodniczuk JS. Philadelphia, Academic Press, 2019CrossrefGoogle Scholar

11 McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87:873–904Crossref, MedlineGoogle Scholar

12 Diamond D, Stovall-McClough C, Clarkin JF, et al.: Patient-therapist attachment in the treatment of borderline personality disorder. Bull Menninger Clin 2003; 67:227–259Crossref, MedlineGoogle Scholar

13 Sbarra DA, Hazan C: Coregulation, dysregulation, self-regulation: an integrative analysis and empirical agenda for understanding adult attachment, separation, loss, and recovery. Pers Soc Psychol Rev 2008; 12:141–167Crossref, MedlineGoogle Scholar

14 Luyten P, Fonagy P: The stress-reward-mentalizing model of depression: an integrative developmental cascade approach to child and adolescent depressive disorder based on the Research Domain Criteria (RDoC) approach. Clin Psychol Rev 2018; 64:87–98Crossref, MedlineGoogle Scholar

15 Mikulincer M, Shaver PR: Attachment in Adulthood: Structure, Dynamics and Change. New York, Guilford Press, 2007Google Scholar

16 Maunder RG, Hunter JJ: Attachment relationships as determinants of physical health. J Am Acad Psychoanal Dyn Psychiatry 2008; 36:11–32Crossref, MedlineGoogle Scholar

17 Luyten P, Mayes LC, Target M, et al.: Developmental research; in Textbook of Psychoanalysis, 2nd ed. Edited by Gabbard GO, Litowitz B, Williams P. Washington, DC, American Psychiatric Association, 2012Google Scholar

18 Luyten P, Van Houdenhove B: Common and specific factors in the psychotherapeutic treatment of patients suffering from chronic fatigue and pain disorders. J Psychother Integration 2013; 23:14–27CrossrefGoogle Scholar

19 Schattner E, Shahar G, Abu-Shakra M: ‘I used to dream of lupus as some sort of creature’: chronic illness as an internal object. Am J Orthopsychiatry 2008; 78:466–472Crossref, MedlineGoogle Scholar

20 Taylor GJ, Bagby RM: Psychoanalysis and empirical research: the example of alexithymia. J Am Psychoanal Assoc 2013; 61:99–133Crossref, MedlineGoogle Scholar

21 Lane RD, Quinlan DM, Schwartz GE, et al.: The Levels of Emotional Awareness Scale: a cognitive-developmental measure of emotion. J Pers Assess 1990; 55:124–134Crossref, MedlineGoogle Scholar

22 Blom D, Thomaes S, Kool MB, et al.: A combination of illness invalidation from the work environment and helplessness is associated with embitterment in patients with FM. Rheumatology 2012; 51:347–353Crossref, MedlineGoogle Scholar

23 Luyten P, Abbass A: What is the evidence for specific factors in the psychotherapeutic treatment of fibromyalgia? Comment on “Is brief psychodynamic psychotherapy in primary fibromyalgia syndrome with concurrent depression an effective treatment? A randomized controlled trial”. Gen Hosp Psychiatry 2013; 35:675–676MedlineGoogle Scholar

24 Luyten P, Fonagy P: An integrative, attachment-based approach to the management and treatment of patients with persistent somatic complaints; in Improving Patient Treatment with Attachment Theory: A Guide for Primary Care Practitioners and Specialists. Edited by Hunter J, Maunder R. New York, Springer, 2016CrossrefGoogle Scholar